Evidence map›Paper›PMID 37813698›Full record

ArticleJournal of cerebrovascular and endovascular neurosurgery2024

Transcranial Doppler emboli monitoring for stroke prevention after flow diverting stents.

Matias Costa, Paul Schmitt, Jaleel N, Matias Baldoncini, Juan Vivanco-Suarez, Bipin Chaurasia, Colleen Douville, Loh Yince, Akshal Patel, Stephen Monteith

Open access · diamondAbstract read
In one paragraph

Article in Journal of cerebrovascular and endovascular neurosurgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 71% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Matias CostaDepartment of Neurosurgery, Swedish Neuroscience Institute, Seattle, Washington, USA.
Paul SchmittDepartment of Neurosurgery, University of Texas Medical Branch, Texas, USA.
Jaleel NDepartment of Neurosurgery, Swedish Neuroscience Institute, Seattle, Washington, USA.
Matias BaldonciniDepartment of Neurological Surgery, Hospital San Fernando, Buenos Aaires, Argentina.
Juan Vivanco-SuarezDepartment of Neurosurgery, Swedish Neuroscience Institute, Seattle, Washington, USA.
Bipin ChaurasiaDepartment of Neurosurgery, Neurosurgery Clinic, Birgunj, Nepal.
Colleen DouvilleDepartment of Neurosurgery, Swedish Neuroscience Institute, Seattle, Washington, USA.
Loh YinceDepartment of Neurosurgery, Swedish Neuroscience Institute, Seattle, Washington, USA.
Akshal PatelDepartment of Neurosurgery, Swedish Neuroscience Institute, Seattle, Washington, USA.
Stephen MonteithDepartment of Neurosurgery, Swedish Neuroscience Institute, Seattle, Washington, USA.
Swedish Medical Center · USDartmouth–Hitchcock Medical Center · USBir Hospital · NP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveFlow diverting stents (FDS) are increasingly used for the treatment of intracranial aneurysms. While FDS can provide flow diversion of parent vessels, their high metal surface coverage can cause thromboembolism. Transcranial Doppler (TCD) emboli monitoring can be used to identify subclinical embolic phenomena after neurovascular procedures. Limited data exists regarding the use of TCDs for emboli monitoring in the periprocedural period after FDS placement. We evaluated the rate of positive TCDs microembolic signals and stroke after FDS deployment at our institution.

methodsWe retrospectively evaluated 105 patients who underwent FDS treatment between 2012 and 2016 using the Pipeline stent (Medtronic, Minneapolis, MN, USA). Patients were pretreated with aspirin and clopidogrel. All patients were therapeutic on clopidogrel pre-operatively. TCD emboli monitoring was performed immediately after the procedure. Microembolic signals (mES) were classified as "positive" (<15 mES/hour) and "strongly positive" (>15 mES/hour). Clinical stroke rates were determined at 2-week and 6-month post-operatively.

resultsA total of 132 intracranial aneurysms were treated in 105 patients. TCD emboli monitoring was "positive" in 11.4% (n=12) post-operatively and "strongly positive" in 4.8% (n=5). These positive cases were treated with heparin drips or modification of the antiplatelet regimen, and TCDs were repeated. Following medical management modifications, normalization of mES was achieved in 92% of cases. The overall stroke rates at 2-week and 6-months were 3.8% and 4.8%, respectively.

conclusionsTCD emboli monitoring may help early in the identification of thromboembolic events after flow diversion stenting. This allows for modification of medical therapy and, potentially, preventionf of escalation into post-operative strokes.

Indexed as

Endovascular stentFlow diverterIntracranial aneurysmTranscranial Doppler Ultrasonography

Identifiers

PMID37813698
PMCPMC10995465
OpenAlexW4387442504

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.